201 related articles for article (PubMed ID: 9607023)
1. Recombinant cholera toxin B subunit acts as an adjuvant for the mucosal and systemic responses of mice to mucosally co-administered bovine serum albumin.
Tochikubo K; Isaka M; Yasuda Y; Kozuka S; Matano K; Miura Y; Taniguchi T
Vaccine; 1998; 16(2-3):150-5. PubMed ID: 9607023
[TBL] [Abstract][Full Text] [Related]
2. Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.
Isaka M; Yasuda Y; Taniguchi T; Kozuka S; Matano K; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
Vaccine; 2003 Mar; 21(11-12):1165-73. PubMed ID: 12559794
[TBL] [Abstract][Full Text] [Related]
3. Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant.
Wu HY; Russell MW
Vaccine; 1998; 16(2-3):286-92. PubMed ID: 9607044
[TBL] [Abstract][Full Text] [Related]
4. Induction of systemic and mucosal antibody responses in mice immunized intranasally with aluminium-non-adsorbed diphtheria toxoid together with recombinant cholera toxin B subunit as an adjuvant.
Isaka M; Yasuda Y; Kozuka S; Taniguchi T; Matano K; Maeyama J; Komiya T; Ohkuma K; Goto N; Tochikubo K
Vaccine; 1999 Nov; 18(7-8):743-51. PubMed ID: 10547435
[TBL] [Abstract][Full Text] [Related]
5. Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant hepatitis B surface antigen and recombinant cholera toxin B subunit as an adjuvant.
Isaka M; Yasuda Y; Mizokami M; Kozuka S; Taniguchi T; Matano K; Maeyama J; Mizuno K; Morokuma K; Ohkuma K; Goto N; Tochikubo K
Vaccine; 2001 Jan; 19(11-12):1460-6. PubMed ID: 11163669
[TBL] [Abstract][Full Text] [Related]
6. Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit.
Isaka M; Yasuda Y; Kozuka S; Miura Y; Taniguchi T; Matano K; Goto N; Tochikubo K
Vaccine; 1998 Oct; 16(17):1620-6. PubMed ID: 9713937
[TBL] [Abstract][Full Text] [Related]
7. Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria-pertussis-tetanus (DPT) combination vaccine.
Isaka M; Komiya T; Takahashi M; Yasuda Y; Taniguchi T; Zhao Y; Matano K; Matsui H; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
Vaccine; 2004 Aug; 22(23-24):3061-8. PubMed ID: 15297056
[TBL] [Abstract][Full Text] [Related]
8. Induction of immune responses and prevention of alveolar bone loss by intranasal administration of mice with Porphyromonas gingivalis fimbriae and recombinant cholera toxin B subunit.
Takahashi Y; Kumada H; Hamada N; Haishima Y; Ozono S; Isaka M; Yasuda Y; Tochikubo K; Umemoto T
Oral Microbiol Immunol; 2007 Dec; 22(6):374-80. PubMed ID: 17949339
[TBL] [Abstract][Full Text] [Related]
9. Safety evaluation of recombinant cholera toxin B subunit produced by Bacillus brevis as a mucosal adjuvant.
Goto N; Maeyama J; Yasuda Y; Isaka M; Matano K; Kozuka S; Taniguchi T; Miura Y; Ohkuma K; Tochikubo K
Vaccine; 2000 Apr; 18(20):2164-71. PubMed ID: 10715532
[TBL] [Abstract][Full Text] [Related]
10. Recombinant cholera toxin B subunit is not an effective mucosal adjuvant for oral immunization of mice against Helicobacter felis.
Blanchard TG; Lycke N; Czinn SJ; Nedrud JG
Immunology; 1998 May; 94(1):22-7. PubMed ID: 9708182
[TBL] [Abstract][Full Text] [Related]
11. [Immunopotency of the recombinant urease B subunit vaccine of Helicobacter pylori after intranasal administration to mice].
Gao ZG; Zou QM; Guo G; Guo TS; Zou QM; Zeng WK; Xie QH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):68-70. PubMed ID: 15132912
[TBL] [Abstract][Full Text] [Related]
12. Frequent nasal administrations of recombinant cholera toxin B subunit (rCTB)-containing tetanus and diphtheria toxoid vaccines induced antigen-specific serum and mucosal immune responses in the presence of anti-rCTB antibodies.
Yasuda Y; Isaka M; Taniguchi T; Zhao Y; Matano K; Matsui H; Morokuma K; Maeyama J; Ohkuma K; Goto N; Tochikubo K
Vaccine; 2003 Jun; 21(21-22):2954-63. PubMed ID: 12798639
[TBL] [Abstract][Full Text] [Related]
13. Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle.
Kozlowski PA; Williams SB; Lynch RM; Flanigan TP; Patterson RR; Cu-Uvin S; Neutra MR
J Immunol; 2002 Jul; 169(1):566-74. PubMed ID: 12077289
[TBL] [Abstract][Full Text] [Related]
14. A comparison of natural and recombinant cholera toxin B subunit as stimulatory factors in intranasal immunization.
de Geus B; Dol-Bosman M; Scholten JW; Stok W; Bianchi A
Vaccine; 1997 Jul; 15(10):1110-3. PubMed ID: 9269054
[TBL] [Abstract][Full Text] [Related]
15. RhinoVax is an efficient adjuvant in oral immunisation of young chickens and cholera toxin B is an effective oral primer in subcutaneous immunisation with Freund's incomplete adjuvant.
Mayo SL; Tufvesson M; Carlsson HE; Royo F; Gizurarson S; Hau J
In Vivo; 2005; 19(2):375-82. PubMed ID: 15796200
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice.
Isaka M; Zhao Y; Nobusawa E; Nakajima S; Nakajima K; Yasuda Y; Matsui H; Hasegawa T; Maeyama J; Morokuma K; Ohkuma K; Tochikubo K
Microbiol Immunol; 2008 Feb; 52(2):55-63. PubMed ID: 18380802
[TBL] [Abstract][Full Text] [Related]
17. Intranasal sensitization of Japanese cedar pollen by the co-administration of low doses of cholera toxin but not its recombinant B subunit to mice.
Hirai T; Hashiguchi S; Torigoe N; Toda Y; Ito Y; Sugimur K
Microbiol Immunol; 2000; 44(4):259-66. PubMed ID: 10832969
[TBL] [Abstract][Full Text] [Related]
18. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
[TBL] [Abstract][Full Text] [Related]
19. Combined oral/nasal immunization protects mice from Sendai virus infection.
Nedrud JG; Liang XP; Hague N; Lamm ME
J Immunol; 1987 Nov; 139(10):3484-92. PubMed ID: 2824609
[TBL] [Abstract][Full Text] [Related]
20. Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina.
Bergquist C; Johansson EL; Lagergård T; Holmgren J; Rudin A
Infect Immun; 1997 Jul; 65(7):2676-84. PubMed ID: 9199436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
